{"parse":{"title":"VigiBase","pageid":46226063,"revid":816937605,"text":{"*":"<div class=\"mw-parser-output\"><p><b>VigiBase</b> is a <a href=\"/wiki/World_Health_Organization\" title=\"World Health Organization\">World Health Organization</a>\u2019s (WHO) global Individual Case Safety Report (ICSR) database that contains ICSRs submitted by the participating member states enrolled under WHO\u2019s international drug monitoring programme. It is the single largest drug safety data repository in the world. Since 1978, the <a href=\"/wiki/Uppsala_Monitoring_Centre\" title=\"Uppsala Monitoring Centre\">Uppsala Monitoring Centre</a> (UMC; established in <a href=\"/wiki/Uppsala\" title=\"Uppsala\">Uppsala</a>, <a href=\"/wiki/Sweden\" title=\"Sweden\">Sweden</a>) on behalf of WHO, have been maintaining VigiBase.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\nVigibase is used to obtain the information about a safety profile of a medicinal product. These data are used by pharmaceutical industries, academic institutions and regulatory authorities for statistical signal detection, updating periodic reports, ICSR comparisons with company databases and studying the reporting patterns.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\nThe data (pre-dominantly post-marketing serious and non-serious cases) is collected from each of its 110 member states which currently comprises to over 10 million ICSRs (October 2014).<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> About a hundred thousand ICSRs are added each year.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Historical_events\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Historical events</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Organisation\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Organisation</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Contributors\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Contributors</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Beneficiaries\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Beneficiaries</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Functioning\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Functioning</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Associated_databases\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Associated databases</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Requirements\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Requirements</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Historical_events\">Historical events</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=1\" title=\"Edit section: Historical events\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li>1957- <a href=\"/wiki/Thalidomide\" title=\"Thalidomide\">Thalidomide</a> tragedy.</li>\n<li>1968- WHO Programme established with 10 member states. International ADR terminology and drug dictionary.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup></li>\n<li>1969- Definition of <a href=\"/wiki/Adverse_drug_reaction\" title=\"Adverse drug reaction\">Adverse drug reaction</a>.</li>\n<li>1978- Operations transferred to the UMC (Uppsala) from WHO (<a href=\"/wiki/Geneva\" title=\"Geneva\">Geneva</a>); setting-up of <a href=\"/wiki/Relational_database_management_system\" title=\"Relational database management system\">relational database management system</a>.</li>\n<li>1991- On-line WHO database search programme available to national centre.</li>\n<li>1993- A documentation grading field was added to VigiBase.</li>\n<li>1998- The UMC implemented an automated signal detection method, using a BCPNN data mining approach.</li>\n<li>2001- Start of Vigibase Online project (now VigiFlow).</li>\n<li>2010- 100th country joins the WHO Programme for International Drug Monitoring.</li>\n<li>2014- Over 10 million adverse reaction reported in VigiBase. Also started to include a larger quantity of more regular submissions from China.</li></ul>\n<p><br />\n</p>\n<h2><span class=\"mw-headline\" id=\"Organisation\">Organisation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=2\" title=\"Edit section: Organisation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Contributors\">Contributors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=3\" title=\"Edit section: Contributors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>It is mandatory for all the participating countries (125 members states and 28 associate members) to submit ICSRs to UMC via its appointed national centre based in the respective member states, authorized by its <a href=\"/wiki/Competent_authority\" title=\"Competent authority\">competent authority</a> or the <a href=\"/wiki/Health_authority\" title=\"Health authority\">health authority</a> itself.  \nThese reports are usually sent to the respective national centre by marketing authorization holders, health care professionals (HCP), consumers or any regional centre. Most of participating member have a well established system for collection of ICSRs.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\nThese submissions are in <a href=\"/wiki/International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use\" title=\"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use\">ICH</a> E2B format and are reported more than once a month or at least every quarter. For some member states that lack an E2B compatible database for ICSR management, UMC in collaboration with \u2018\u2019Swissmedic\u2019\u2019 has developed \u2018\u2019VigiFlow\u2019\u2019, a web-based ICSR management system. VigiFlow functions as a national ICSR database management system and analysis tool, through which cases are sent to UMC.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Beneficiaries\">Beneficiaries</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=4\" title=\"Edit section: Beneficiaries\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>With primary objective of identify the earliest possible <a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">pharmacovigilance</a> signals, the usage of VigiBase is permitted and accessed by the following authorities:<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<ol><li>Member states: Authorized centre of all member countries have the free access to the data through \u2018\u2019VigiSearch\u2019\u2019/ \u2018\u2019VigiLyze\u2019\u2019, or can be requested for data to UMC. Although these data would not contain narratives or laboratory values of the patient, in order to maintain the confidentiality.</li>\n<li>UMC:  Signal review team and UMC employees have full access to data, including narratives and laboratory values.</li>\n<li>Paying customers: Pharmaceutical companies or HCPs can request for the data by paying stipulated fees, provided the data is being used for academic purposes or in public interest.</li></ol>\n<h2><span class=\"mw-headline\" id=\"Functioning\">Functioning</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=5\" title=\"Edit section: Functioning\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Associated_databases\">Associated databases</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=6\" title=\"Edit section: Associated databases\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>VigiBase is a <a href=\"/wiki/Relational_database_management_system\" title=\"Relational database management system\">relational database management system</a> (RDMS) which is compatible with ODBC (<a href=\"/wiki/Open_database_connectivity\" class=\"mw-redirect\" title=\"Open database connectivity\">open database connectivity</a>) and uses <a href=\"/wiki/SQL\" title=\"SQL\">SQL</a> for the database communication. The RDMS can be accessed through client server applications, ODBC, and Internet applications. Apart from data management, the VigiBase system includes an automated signal detection process using advanced data mining tools (\u2018\u2019VigiMine\u2019\u2019- a Bayesian Confidence Propagation Neural Network (BCPNN) data mining tool).<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> VigiBase further includes a WHO Drug Dictionaries (WHO-DD and -DDE), and medical terminology dictionary such as WHO Adverse Reaction Terminology (WHO-ART), <a href=\"/wiki/International_Classification_of_Diseases\" class=\"mw-redirect\" title=\"International Classification of Diseases\">International Classification of Diseases</a> (ICD), and the <a href=\"/wiki/Medical_Dictionary_for_Regulatory_Activities\" class=\"mw-redirect\" title=\"Medical Dictionary for Regulatory Activities\">Medical Dictionary for Regulatory Activities</a> (MedDRA).<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Requirements\">Requirements</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=7\" title=\"Edit section: Requirements\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Type of reports: Most preferred data includes post-marketing spontaneous serious and non-serious cases ICSRs. Case reports from studies, <a href=\"/wiki/Clinical_trials\" class=\"mw-redirect\" title=\"Clinical trials\">clinical trials</a> or special monitoring and literature are sometimes included, but are flagged.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\nType of medicine: Database includes ICSRs on ordinary <a href=\"/wiki/Allopathic\" class=\"mw-redirect\" title=\"Allopathic\">allopathic</a> medicines, traditional medicines (herbals), biologics, <a href=\"/wiki/Vaccines\" class=\"mw-redirect\" title=\"Vaccines\">vaccines</a> and <a href=\"/wiki/Medical_devices\" class=\"mw-redirect\" title=\"Medical devices\">medical devices</a>. In addition, ICSRs on medication errors, therapeutic failure and counterfeit/substandard medicines are also considered.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=8\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/International_Conference_on_Harmonisation_of_Technical_Requirements_for_Registration_of_Pharmaceuticals_for_Human_Use\" class=\"mw-redirect\" title=\"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use\">International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use</a> (ICH)</li>\n<li><a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">Council for International Organizations of Medical Sciences</a> (CIOMS)</li>\n<li><a href=\"/wiki/International_Society_of_Pharmacovigilance\" title=\"International Society of Pharmacovigilance\">International Society of Pharmacovigilance</a></li>\n<li><a href=\"/wiki/Society_of_Pharmacovigilance,_India\" title=\"Society of Pharmacovigilance, India\">Society of Pharmacovigilance, India</a></li>\n<li><a href=\"/wiki/EudraVigilance\" title=\"EudraVigilance\">EudraVigilance</a> (EEA)</li>\n<li><a href=\"/wiki/Yellow_Card_Scheme\" title=\"Yellow Card Scheme\">Yellow Card Scheme</a> (UK)</li>\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a></li>\n<li><a href=\"/wiki/Drug_development\" title=\"Drug development\">Drug development</a></li>\n<li><a href=\"/wiki/MedDRA\" title=\"MedDRA\">MedDRA</a></li>\n<li><a href=\"/wiki/WHOART\" title=\"WHOART\">WHOART</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=9\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\">Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. <i>Drug Information Journal</i>, 2008, 42:409\u2013419.</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.who-umc.org/vigibase/vigibase/\">https://www.who-umc.org/vigibase/vigibase/</a></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.who-umc.org/vigibase/vigibase/\">https://www.who-umc.org/vigibase/vigibase/</a></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\">Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. <i>Drug Information Journal</i>, 2008, 42:409\u2013419.</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members\">https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members</a></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.bridgetodata.org/node/1063\">http://www.bridgetodata.org/node/1063</a></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.who-umc.org/vigibase/vigibase/know-more-about-vigibase/\">https://www.who-umc.org/vigibase/vigibase/know-more-about-vigibase/</a></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\">Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. <i>Drug Information Journal</i>, 2008, 42:409\u2013419.</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/WHO/\">https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/WHO/</a></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.bridgetodata.org/node/1063\">http://www.bridgetodata.org/node/1063</a></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.bridgetodata.org/node/1063\">http://www.bridgetodata.org/node/1063</a></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=VigiBase&amp;action=edit&amp;section=10\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external autonumber\" href=\"http://www.who-umc.org\">[1]</a>, Uppsala Monitoring Centre home</li>\n<li><a rel=\"nofollow\" class=\"external autonumber\" href=\"https://who-umc.org/safer-use-of-medicines/uppsala-reports/\">[2]</a>, Uppsala Reports is the UMC's regular news bulletin for everyone concerned with the issues of pharmacovigilance.</li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2201\nCached time: 20180920172411\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.048 seconds\nReal time usage: 0.063 seconds\nPreprocessor visited node count: 237/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 308/2097152 bytes\nTemplate argument size: 72/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 4126/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.003/10.000 seconds\nLua memory usage: 525 KB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%   26.781      1 Template:Reflist\n100.00%   26.781      1 -total\n  7.29%    1.952      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:46226063-0!canonical and timestamp 20180920172411 and revision id 816937605\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"World_Health_Organization"},{"sortkey":"","*":"Pharmacological_classification_systems"},{"sortkey":"","*":"Pharmaceuticals_policy"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"Organizations_established_in_1978"}],"links":[{"ns":0,"exists":"","*":"Adverse drug reaction"},{"ns":0,"exists":"","*":"Allopathic"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Clinical trials"},{"ns":0,"exists":"","*":"Competent authority"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Drug development"},{"ns":0,"exists":"","*":"EudraVigilance"},{"ns":0,"exists":"","*":"Geneva"},{"ns":0,"exists":"","*":"Health authority"},{"ns":0,"exists":"","*":"International Classification of Diseases"},{"ns":0,"exists":"","*":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use"},{"ns":0,"exists":"","*":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use"},{"ns":0,"exists":"","*":"International Society of Pharmacovigilance"},{"ns":0,"exists":"","*":"MedDRA"},{"ns":0,"exists":"","*":"Medical Dictionary for Regulatory Activities"},{"ns":0,"exists":"","*":"Medical devices"},{"ns":0,"exists":"","*":"Open database connectivity"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Relational database management system"},{"ns":0,"exists":"","*":"SQL"},{"ns":0,"exists":"","*":"Society of Pharmacovigilance, India"},{"ns":0,"exists":"","*":"Sweden"},{"ns":0,"exists":"","*":"Thalidomide"},{"ns":0,"exists":"","*":"Uppsala"},{"ns":0,"exists":"","*":"Uppsala Monitoring Centre"},{"ns":0,"exists":"","*":"Vaccines"},{"ns":0,"exists":"","*":"WHOART"},{"ns":0,"exists":"","*":"World Health Organization"},{"ns":0,"exists":"","*":"Yellow Card Scheme"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["https://www.who-umc.org/vigibase/vigibase/","https://www.who-umc.org/global-pharmacovigilance/members/who-programme-members","http://www.bridgetodata.org/node/1063","https://www.who-umc.org/vigibase/vigibase/know-more-about-vigibase/","https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/WHO/","http://www.who-umc.org","https://who-umc.org/safer-use-of-medicines/uppsala-reports/"],"sections":[{"toclevel":1,"level":"2","line":"Historical events","number":"1","index":"1","fromtitle":"VigiBase","byteoffset":1250,"anchor":"Historical_events"},{"toclevel":1,"level":"2","line":"Organisation","number":"2","index":"2","fromtitle":"VigiBase","byteoffset":2250,"anchor":"Organisation"},{"toclevel":2,"level":"3","line":"Contributors","number":"2.1","index":"3","fromtitle":"VigiBase","byteoffset":2268,"anchor":"Contributors"},{"toclevel":2,"level":"3","line":"Beneficiaries","number":"2.2","index":"4","fromtitle":"VigiBase","byteoffset":3472,"anchor":"Beneficiaries"},{"toclevel":1,"level":"2","line":"Functioning","number":"3","index":"5","fromtitle":"VigiBase","byteoffset":4330,"anchor":"Functioning"},{"toclevel":2,"level":"3","line":"Associated databases","number":"3.1","index":"6","fromtitle":"VigiBase","byteoffset":4347,"anchor":"Associated_databases"},{"toclevel":2,"level":"3","line":"Requirements","number":"3.2","index":"7","fromtitle":"VigiBase","byteoffset":5349,"anchor":"Requirements"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"8","fromtitle":"VigiBase","byteoffset":5983,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"9","fromtitle":"VigiBase","byteoffset":6419,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"10","fromtitle":"VigiBase","byteoffset":6447,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"VigiBase","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q19757574"}]}}